7.79600 EUR
0.22
2.74%
Last update Dec 15, 8:01 AM CET
Main market
Day range
7.79600
7.79600
Previous close
8.016000
Open
7.79600
Access this stock data via API
Subscribe
Intellia Therapeutics Inc.
7.80
0.22
2.74%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 49.3M 36.3M 52.1M 33.1M
Cost of revenue
Gross profit
Operating expense
Research & development 397.4M 435.1M 420.0M 229.8M
Selling general and admin 107.2M 116.5M 90.3M 71.1M
Other operating expenses
Operating income -455.3M -515.3M -458.2M -267.9M
Non operating interest income
Income 40.7M 49.8M 8.5M 1.3M
Expense
Other income expense -27.8M -15.7M -24.6M -1.3M
Pretax income -442.3M -481.2M -474.2M -267.9M
Tax provision
Net income -442.3M -481.2M -474.2M -267.9M
Basic EPS -5.3 -5.4 -6.2 -3.8
Diluted EPS -5.3 -5.4 -6.2 -3.8
Basic average shares 84.2M 92.3M 80.1M 73.8M
Diluted average shares 84.2M 92.3M 80.1M 73.8M
EBITDA -418.8M -506.2M -437.1M -261.0M
Net income from continuing op. -442.3M -481.2M -474.2M -267.9M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 11 hours 36 minutes

08:23
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).